Soluble biomarkers development in osteoarthritis: from discovery to personalized medicine

OARSI Clinical Trials Recommendations: Soluble biomarker assessments in clinical trials in osteoarthritis

(2015) V.B. Kraus et al.   OSTEOARTHRITIS AND CARTILAGE

Biomarkers and proteomic analysis of osteoarthritis

(2014) Ming-Feng Hsueh et al.   MATRIX BIOLOGY

Value of biomarkers in osteoarthritis: current status and perspectives

(2013) M Lotz et al.   ANNALS OF THE RHEUMATIC DISEASES

Osteoarthritis – a case for personalized health care?

(2013) M.A. Karsdal et al.   OSTEOARTHRITIS AND CARTILAGE

Fibulin 3 peptides Fib3-1 and Fib3-2 are potential biomarkers of osteoarthritis

(2012) Yves Henrotin et al.   ARTHRITIS AND RHEUMATISM

Why subchondral bone in osteoarthritis? The importance of the cartilage bone interface in osteoarthritis

(2012) M. Mahjoub et al.   OSTEOPOROSIS INTERNATIONAL

Biomarkers and surrogate endpoints in clinical trials

(2012) Thomas R. Fleming et al.   STATISTICS IN MEDICINE

Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis

(2011) V.B. Kraus et al.   OSTEOARTHRITIS AND CARTILAGE

Application for Proteomic Techniques in Studying Osteoarthritis: A Review

(2011) Myriam Gharbi et al.   Frontiers in Physiology

Is Urinary Sarcosine Useful to Identify Patients With Significant Prostate Cancer? The Trials and Tribulations of Biomarker Development

(2010) Jack A. Schalken   EUROPEAN UROLOGY

Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria

(2010) W.E. van Spil et al.   OSTEOARTHRITIS AND CARTILAGE